4-hydroxyacetophenone has been researched along with Pancreatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anders, RA; DiNapoli, KT; Guck, J; Herbig, M; Iglesias, PA; Jacobi, A; Jaffee, EM; Kräter, M; Otto, O; Plak, K; Robinson, DN; Schiffhauer, ES; Surcel, A; Thomas, DG; West-Foyle, H; Zhu, Q | 1 |
| Anders, RA; Avery, LB; Freel Meyers, CL; Krenc, AK; Meyers, DJ; Ng, WP; Ren, Y; Robinson, DN; Rock, RS; Surcel, A; West-Foyle, H; Zhu, Q | 1 |
2 other study(ies) available for 4-hydroxyacetophenone and Pancreatic Neoplasms
| Article | Year |
|---|---|
Targeting Mechanoresponsive Proteins in Pancreatic Cancer: 4-Hydroxyacetophenone Blocks Dissemination and Invasion by Activating MYH14.
Topics: Acetophenones; Actin Cytoskeleton; Actinin; Animals; Apoptosis; Cell Proliferation; Humans; Liver Neoplasms; Mice; Mice, Nude; Myosin Heavy Chains; Myosin Type II; Neoplasm Invasiveness; Pancreatic Neoplasms; Prognosis; Tumor Cells, Cultured; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2019 |
Pharmacological activation of myosin II paralogs to correct cell mechanics defects.
Topics: Acetophenones; Carbamates; HEK293 Cells; HL-60 Cells; Humans; Myosin Type II; Pancreatic Neoplasms; Tumor Cells, Cultured | 2015 |